ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176323 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176323; 2) Community: the network communities that were significantly associated with the response to NSC 176323; 3) Molecule: the relationships between components within communities and NSC 176323; 4) MDR: the compounds that were significantly associated with the NSC 176323.

NSC Compound Enrichment Correlation
NSC 681643 Camptothecin Derivative 0.0430505868034761 0.80784757
NSC 703037 Null 0.0430505868034761 0.12711776
NSC 708559 Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) 0.0430505868034761 -0.083398369
NSC 709483 Null 0.0430505868034761 -0.048969915
NSC 720447 Null 0.0430505868034761 -0.049448956
NSC 726267 Null 0.0430505868034761 0.2875322
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0430505868034761 0.19447329
NSC 733504 Everolimus 0.0430505868034761 0.076991975
NSC 735373 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) 0.0430505868034761 0.26603821
NSC 736157 Null 0.0430505868034761 0.18441529
Total:54  Current:47    [First] [Prev] [Next] [Last]